Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 3Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 4Recurrence 2Obesity, Morbid 1Metabolic Syndrome 1Liver Neoplasms 1Fibrosis 1Disseminated Pancreatic Cancer 1Abdominal Injuries 1

Interventions

Cyclophosphamide 6fludarabine 5toripalimab 3Paclitaxel 3Etoposide 3Carboplatin 3Bevacizumab 3zimberelimab 2tislelizumab 2sintilimab 2glumetinib 2Vincristine 2Temozolomide 2Platinum 2Immune Checkpoint Inhibitors 2Hepatectomy 2Gemcitabine 2Drug Therapy 2Docetaxel 2Cisplatin 2Capecitabine 2venetoclax 1relmacabtagene autoleucel 1osimertinib 1lenvatinib 1irinotecan sucrosofate 1glofitamab 1gallium maltolate 1fludarabine phosphate 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Recurrence × Hepatectomy × Clear all
NCT06311916 2024-03-15

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Tongji Hospital

Phase 4 Not yet recruiting
312 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT04053231 2019-08-12

HERCOLES2

University of Milano Bicocca

Not yet recruiting
3,000 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡